Kira Vadimovna Pyatina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kira Vadimovna Pyatina has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Irina Sergeevna Fadeeva
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
8 shared publications - Margarita Igorevna Kobyakova
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
8 shared publications - Anatoly Sergeevich Senotov
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
7 shared publications - Roman Sergeevich Fadeev
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
7 shared publications - Vladislav Valentinovich Minaychev
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
7 shared publications - Anasia Yurievna Teterina
Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences, Leninskiy Prospect 49, 119334 Moscow, Russia
6 shared publications
Latest Publications
- Open Access
- 19 June 2025
- Published by ECO-Vector LLC in Morphology
- Vol. 163 (3) , 220-233
Biocompatibility of barium-doped dicalcium phosphate dihydrate obtained via low-temperature synthesis for use in regenerative medicine
BACKGROUND: Synthetic materials based on calcium phosphate compounds (CPCs) are increasingly used in modern regenerative medicine to stimulate bone tissue regeneration. AIM: The work aimed to assess key parameters of biocompatibility in vitro, including the content of acidic compartments and reactive oxygen species production, during the interaction of human macrophages with low-temperature-synthesized barium doped dicalcium phosphate dihydrate under normal and lipopolysaccharide (LPS)-induced inflammatory conditions. METHODS: Morphology and qualitative and quantitative elemental composition of dicalcium phosphate dihydrate (DCPD) powder and its barium-doped form (DCPD-Ba) were evaluated using scanning electron microscopy, infrared spectroscopy, energy-dispersive X-ray spectroscopy, and X-ray diffraction. Cell viability, lysosomal content, and reactive oxygen species production were assessed by flow cytometry after co-culturing primary human macrophages with DCPD and DCPD-Ba under both normal and LPS-stimulated conditions. RESULTS: Barium-doped DCPD samples were synthesized using a low-temperature method at Ba²⁺ concentrations of 1%, 5%, and 10% of the theoretically possible substitution level (theor.%). For each variant, the calculated actual substitution percentage amounted to 0.62, 1.43, and 6.43 atomic %, respectively. X-ray diffraction analysis confirmed complete transformation of the initial α-tricalcium phosphate into DCPD at all Ba2+ concentrations. The infrared spectroscopy data validated the conformity of DCPD structure to the reference standard across all Ba2+ doping levels. Doping with Ba2+ ions has been found to enhance the hydration activity of DCPD and cause deformation of its crystal structure. The results of in vitro studies indicate that substitution of Ca2+ with Ba2+ in the DCPD structure does not affect the cytotoxic properties of the material. Furthermore, DCPD-Ba did not suppress lysosomal biogenesis and promoted reactive oxygen species production in non-activated macrophages, whereas suppressing reactive oxygen species production under LPS-induced inflammatory conditions. CONCLUSION: Thus, both DCPD and its Ba substituted variants represent promising candidates for incorporation into materials intended for regenerative medicine. The proposed low temperature synthesis of Ba2+-substituted DCPD is of considerable interest for the development of specialized osteoplastic CPC based materials. The most effective DCPD variant, with the highest Ca2+-to-Ba2+ substitution level (6.43 atomic %), demonstrated potential regulatory activity on activated macrophages (i.e., under inflammatory conditions). This property may be of critical importance for modulating the immune response and promoting effective osteointegration of the material in the recipient’s body.
- 19 June 2025
- Published by ECO-Vector LLC in Morphology
- Vol. 163 (3) , 220-233
Open AccessBiocompatibility of barium-doped dicalcium phosphate dihydrate obtained via low-temperature synthesis for use in regenerative medicine
BACKGROUND: Synthetic materials based on calcium phosphate compounds (CPCs) are increasingly used in modern regenerative medicine to stimulate bone tissue regeneration. AIM: The work aimed to assess key parameters of biocompatibility in vitro, including the content of acidic compartments and reactive oxygen species production, during the interaction of human macrophages with low-temperature-synthesized barium doped dicalcium phosphate dihydrate under normal and lipopolysaccharide (LPS)-induced inflammatory conditions. METHODS: Morphology and qualitative and quantitative elemental composition of dicalcium phosphate dihydrate (DCPD) powder and its barium-doped form (DCPD-Ba) were evaluated using scanning electron microscopy, infrared spectroscopy, energy-dispersive X-ray spectroscopy, and X-ray diffraction. Cell viability, lysosomal content, and reactive oxygen species production were assessed by flow cytometry after co-culturing primary human macrophages with DCPD and DCPD-Ba under both normal and LPS-stimulated conditions. RESULTS: Barium-doped DCPD samples were synthesized using a low-temperature method at Ba²⁺ concentrations of 1%, 5%, and 10% of the theoretically possible substitution level (theor.%). For each variant, the calculated actual substitution percentage amounted to 0.62, 1.43, and 6.43 atomic %, respectively. X-ray diffraction analysis confirmed complete transformation of the initial α-tricalcium phosphate into DCPD at all Ba2+ concentrations. The infrared spectroscopy data validated the conformity of DCPD structure to the reference standard across all Ba2+ doping levels. Doping with Ba2+ ions has been found to enhance the hydration activity of DCPD and cause deformation of its crystal structure. The results of in vitro studies indicate that substitution of Ca2+ with Ba2+ in the DCPD structure does not affect the cytotoxic properties of the material. Furthermore, DCPD-Ba did not suppress lysosomal biogenesis and promoted reactive oxygen species production in non-activated macrophages, whereas suppressing reactive oxygen species production under LPS-induced inflammatory conditions. CONCLUSION: Thus, both DCPD and its Ba substituted variants represent promising candidates for incorporation into materials intended for regenerative medicine. The proposed low temperature synthesis of Ba2+-substituted DCPD is of considerable interest for the development of specialized osteoplastic CPC based materials. The most effective DCPD variant, with the highest Ca2+-to-Ba2+ substitution level (6.43 atomic %), demonstrated potential regulatory activity on activated macrophages (i.e., under inflammatory conditions). This property may be of critical importance for modulating the immune response and promoting effective osteointegration of the material in the recipient’s body.
- Open Access
- 24 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (2) , 263
Low-Temperature Calcium Phosphate Ceramics Can Modulate Monocytes and Macrophages Inflammatory Response In Vitro
Creating bioactive materials for bone tissue regeneration and augmentation remains a pertinent challenge. One of the most promising and rapidly advancing approaches involves the use of low-temperature ceramics that closely mimic the natural composition of the extracellular matrix of native bone tissue, such as Hydroxyapatite (HAp) and its phase precursors (Dicalcium Phosphate Dihydrate—DCPD, Octacalcium Phosphate—OCP, etc.). However, despite significant scientific interest, the current knowledge and understanding remain limited regarding the impact of these ceramics not only on reparative histogenesis processes but also on the immunostimulation and initiation of local aseptic inflammation leading to material rejection. Using the stable cell models of monocyte-like (THP-1ATRA) and macrophage-like (THP-1PMA) cells under the conditions of LPS-induced model inflammation in vitro, the influence of DCPD, OCP, and HAp on cell viability, ROS and intracellular NO production, phagocytosis, and the secretion of pro-inflammatory cytokines was assessed. The results demonstrate that all investigated ceramic particles exhibit biological activity toward human macrophage and monocyte cells in vitro, potentially providing conditions necessary for bone tissue restoration/regeneration in the peri-implant environment in vivo. Among the studied ceramics, DCPD appears to be the most preferable for implantation in patients with latent inflammation or unpredictable immune status, as this ceramic had the most favorable overall impact on the investigated cellular models.
- 24 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (2) , 263
Open AccessLow-Temperature Calcium Phosphate Ceramics Can Modulate Monocytes and Macrophages Inflammatory Response In Vitro
Creating bioactive materials for bone tissue regeneration and augmentation remains a pertinent challenge. One of the most promising and rapidly advancing approaches involves the use of low-temperature ceramics that closely mimic the natural composition of the extracellular matrix of native bone tissue, such as Hydroxyapatite (HAp) and its phase precursors (Dicalcium Phosphate Dihydrate—DCPD, Octacalcium Phosphate—OCP, etc.). However, despite significant scientific interest, the current knowledge and understanding remain limited regarding the impact of these ceramics not only on reparative histogenesis processes but also on the immunostimulation and initiation of local aseptic inflammation leading to material rejection. Using the stable cell models of monocyte-like (THP-1ATRA) and macrophage-like (THP-1PMA) cells under the conditions of LPS-induced model inflammation in vitro, the influence of DCPD, OCP, and HAp on cell viability, ROS and intracellular NO production, phagocytosis, and the secretion of pro-inflammatory cytokines was assessed. The results demonstrate that all investigated ceramic particles exhibit biological activity toward human macrophage and monocyte cells in vitro, potentially providing conditions necessary for bone tissue restoration/regeneration in the peri-implant environment in vivo. Among the studied ceramics, DCPD appears to be the most preferable for implantation in patients with latent inflammation or unpredictable immune status, as this ceramic had the most favorable overall impact on the investigated cellular models.
- Open Access
- 23 January 2024
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 15 (2) , 27
Composite Remineralization of Bone-Collagen Matrices by Low-Temperature Ceramics and Serum Albumin: A New Approach to the Creation of Highly Effective Osteoplastic Materials
This study examined the effectiveness of coating demineralized bone matrix (DBM) with amorphous calcium phosphate (DBM + CaP), as well as a composite of DBM, calcium phosphate, and serum albumin (DBM + CaP + BSA). The intact structure of DBM promotes the transformation of amorphous calcium phosphate (CaP) into dicalcium phosphate dihydrate (DCPD) with a characteristic plate shape and particle size of 5–35 µm. The inclusion of BSA in the coating resulted in a better and more uniform distribution of CaP on the surface of DBM trabeculae. MG63 cells showed that both the obtained forms of CaP and its complex with BSA did not exhibit cytotoxicity up to a concentration of 10 mg/mL in vitro. Ectopic (subcutaneous) implantation in rats revealed pronounced biocompatibility, as well as strong osteoconductive, osteoinductive, and osteogenic effects for both DBM + CaP and DBM + CaP + BSA, but more pronounced effects for DBM + CaP + BSA. In addition, for the DBM + CaP + BSA samples, there was a pronounced full physiological intrafibrillar biomineralization and proangiogenic effect with the formation of bone-morrow-like niches, accompanied by pronounced processes of intramedullary hematopoiesis, indicating a powerful osteogenic effect of this composite.
- 23 January 2024
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 15 (2) , 27
Open AccessComposite Remineralization of Bone-Collagen Matrices by Low-Temperature Ceramics and Serum Albumin: A New Approach to the Creation of Highly Effective Osteoplastic Materials
This study examined the effectiveness of coating demineralized bone matrix (DBM) with amorphous calcium phosphate (DBM + CaP), as well as a composite of DBM, calcium phosphate, and serum albumin (DBM + CaP + BSA). The intact structure of DBM promotes the transformation of amorphous calcium phosphate (CaP) into dicalcium phosphate dihydrate (DCPD) with a characteristic plate shape and particle size of 5–35 µm. The inclusion of BSA in the coating resulted in a better and more uniform distribution of CaP on the surface of DBM trabeculae. MG63 cells showed that both the obtained forms of CaP and its complex with BSA did not exhibit cytotoxicity up to a concentration of 10 mg/mL in vitro. Ectopic (subcutaneous) implantation in rats revealed pronounced biocompatibility, as well as strong osteoconductive, osteoinductive, and osteogenic effects for both DBM + CaP and DBM + CaP + BSA, but more pronounced effects for DBM + CaP + BSA. In addition, for the DBM + CaP + BSA samples, there was a pronounced full physiological intrafibrillar biomineralization and proangiogenic effect with the formation of bone-morrow-like niches, accompanied by pronounced processes of intramedullary hematopoiesis, indicating a powerful osteogenic effect of this composite.
- Open Access
- 28 September 2023
- Published by MDPI AG in Preprints.org
Composite Remineralization of Bone-Collagen Matrices: A New Approach to the Creation of Highly Effective Osteoplastic Materials
In the present study, the efficiency of a biomimetic approach by coating demineralized bone matrix (DBM) amorphous calcium phosphate (DBM+CaP), including its combination with serum albumin (DBM+CaP+BSA), was investigated. The intact structure of DBM promotes the transformation of amorphous calcium phosphate (CaP) into DPCD with a characteristic plate shape and particle size of 5–35 µm. The inclusion of BSA in the coating resulted in a better and more uniform distribution of CaP on the surface of DBM trabeculae. MG63 cells showed that both the obtained forms of CaP and its complex with BSA did not exhibit cytotoxicity up to a concentration of 10 mg/ml in vitro. Ectopic (subcutaneous) implantation in rats revealed pronounced biocompatibility, as well as strong osteoconductive, osteoinductive, and osteogenic effects for both DBM+CaP and DBM+CaP+BSA, but more pronounced effects for DBM+CaP+BSA. In addition, for the DBM+CaP+BSA samples, a pronounced full physiological intrafibrillar biomineralization and proangiogenic effect with the formation of bone-morrow-like niches, accompanied by pronounced processes of intramedullary hematopoiesis, indicating a powerful osteogenic effect of this composite have been achieved.
- 28 September 2023
- Published by MDPI AG in Preprints.org
Open AccessComposite Remineralization of Bone-Collagen Matrices: A New Approach to the Creation of Highly Effective Osteoplastic Materials
In the present study, the efficiency of a biomimetic approach by coating demineralized bone matrix (DBM) amorphous calcium phosphate (DBM+CaP), including its combination with serum albumin (DBM+CaP+BSA), was investigated. The intact structure of DBM promotes the transformation of amorphous calcium phosphate (CaP) into DPCD with a characteristic plate shape and particle size of 5–35 µm. The inclusion of BSA in the coating resulted in a better and more uniform distribution of CaP on the surface of DBM trabeculae. MG63 cells showed that both the obtained forms of CaP and its complex with BSA did not exhibit cytotoxicity up to a concentration of 10 mg/ml in vitro. Ectopic (subcutaneous) implantation in rats revealed pronounced biocompatibility, as well as strong osteoconductive, osteoinductive, and osteogenic effects for both DBM+CaP and DBM+CaP+BSA, but more pronounced effects for DBM+CaP+BSA. In addition, for the DBM+CaP+BSA samples, a pronounced full physiological intrafibrillar biomineralization and proangiogenic effect with the formation of bone-morrow-like niches, accompanied by pronounced processes of intramedullary hematopoiesis, indicating a powerful osteogenic effect of this composite have been achieved.
- Open Access
- 10 August 2023
- Published by MDPI AG in Biomimetics
- Vol. 8 (4) , 357
Soft Biomimetic Approach for the Development of Calcinosis-Resistant Glutaraldehyde-Fixed Biomaterials for Cardiovascular Surgery
Pathological aseptic calcification is the most common form of structural valvular degeneration (SVD), leading to premature failure of heart valve bioprostheses (BHVs). The processing methods used to obtain GA-fixed pericardium-based biomaterials determine the hemodynamic characteristics and durability of BHVs. This article presents a comparative study of the effects of several processing methods on the degree of damage to the ECM of GA-fixed pericardium-based biomaterials as well as on their biostability, biocompatibility, and resistance to calcification. Based on the assumption that preservation of the native ECM structure will enable the creation of calcinosis-resistant materials, this study provides a soft biomimetic approach for the manufacture of GA-fixed biomaterials using gentle decellularization and washing methods. It has been shown that the use of soft methods for preimplantation processing of materials, ensuring maximum preservation of the intactness of the pericardial ECM, radically increases the resistance of biomaterials to calcification. These obtained data are of interest for the development of new calcinosis-resistant biomaterials for the manufacture of BHVs.
- 10 August 2023
- Published by MDPI AG in Biomimetics
- Vol. 8 (4) , 357
Open AccessSoft Biomimetic Approach for the Development of Calcinosis-Resistant Glutaraldehyde-Fixed Biomaterials for Cardiovascular Surgery
Pathological aseptic calcification is the most common form of structural valvular degeneration (SVD), leading to premature failure of heart valve bioprostheses (BHVs). The processing methods used to obtain GA-fixed pericardium-based biomaterials determine the hemodynamic characteristics and durability of BHVs. This article presents a comparative study of the effects of several processing methods on the degree of damage to the ECM of GA-fixed pericardium-based biomaterials as well as on their biostability, biocompatibility, and resistance to calcification. Based on the assumption that preservation of the native ECM structure will enable the creation of calcinosis-resistant materials, this study provides a soft biomimetic approach for the manufacture of GA-fixed biomaterials using gentle decellularization and washing methods. It has been shown that the use of soft methods for preimplantation processing of materials, ensuring maximum preservation of the intactness of the pericardial ECM, radically increases the resistance of biomaterials to calcification. These obtained data are of interest for the development of new calcinosis-resistant biomaterials for the manufacture of BHVs.
- Open Access
- 26 July 2023
- Published by MDPI AG in Preprints.org
Soft Biomimetic Approach for the Development of Calcinosis-Resistant Glutaraldehyde-Fixed Biomaterials for Cardiovascular Surgery
Pathological aseptic calcification is the most common form of structural valvular degeneration (SVD), leading to premature failure of heart valve bioprostheses (BHVs). The processing methods used to obtain GA-fixed pericardium-based biomaterials determine the hemodynamic characteristics and durability of BHVs. This article presents a comparative study of the effects of several processing methods on the degree of damage to the ECM of GA-fixed pericardium-based biomaterials as well as on their biostability, biocompatibility, and resistance to calcification. Based on the assumption that preservation of the native ECM structure will enable the creation of calcinosis-resistant materials, this study provides a soft biomimetic approach for the manufacture of GA-fixed biomaterials using gentle decellularization and washing methods. It has been shown that the use of soft methods for preimplantation processing of materials, ensuring maximum preservation of the intactness of the pericardial ECM, radically increases the resistance of biomaterials to calcification. The data obtained are of interest for the development of new calcinosis-resistant biomaterials for the manufacture of BHVs.
- 26 July 2023
- Published by MDPI AG in Preprints.org
Open AccessSoft Biomimetic Approach for the Development of Calcinosis-Resistant Glutaraldehyde-Fixed Biomaterials for Cardiovascular Surgery
Pathological aseptic calcification is the most common form of structural valvular degeneration (SVD), leading to premature failure of heart valve bioprostheses (BHVs). The processing methods used to obtain GA-fixed pericardium-based biomaterials determine the hemodynamic characteristics and durability of BHVs. This article presents a comparative study of the effects of several processing methods on the degree of damage to the ECM of GA-fixed pericardium-based biomaterials as well as on their biostability, biocompatibility, and resistance to calcification. Based on the assumption that preservation of the native ECM structure will enable the creation of calcinosis-resistant materials, this study provides a soft biomimetic approach for the manufacture of GA-fixed biomaterials using gentle decellularization and washing methods. It has been shown that the use of soft methods for preimplantation processing of materials, ensuring maximum preservation of the intactness of the pericardial ECM, radically increases the resistance of biomaterials to calcification. The data obtained are of interest for the development of new calcinosis-resistant biomaterials for the manufacture of BHVs.
- Open Access
- 15 June 2023
- Published by MDPI AG in Technologies
- Vol. 11 (3) , 77
Injectable Hydrated Calcium Phosphate Bone-like Paste: Synthesis, In Vitro, and In Vivo Biocompatibility Assessment
The injectable hydrated calcium phosphate bone-like paste (hCPP) was developed with suitable rheological characteristics, enabling unhindered injection through standard 23G needles. In vitro assays showed the cytocompatibility of hCPP with mesenchymal embryonic C3H10T1/2 cell cultures. The hCPP was composed of aggregated micro-sized particles with sphere-like shapes and low crystallinity. The ability of hCPP particles to adsorb serum proteins (FBS) was investigated. The hCPP demonstrated high protein adsorption capacity, indicating its potential in various biomedical applications. The results of the in vivo assay upon subcutaneous injection in Wistar rats indicated nontoxicity and biocompatibility of experimental hCPP, as well as gradual resorption of hCPP, comparable to the period of bone regeneration. The data obtained are of great interest for the development of commercial highly effective osteoplastic materials for bone tissue regeneration and augmentation.
- 15 June 2023
- Published by MDPI AG in Technologies
- Vol. 11 (3) , 77
Open AccessInjectable Hydrated Calcium Phosphate Bone-like Paste: Synthesis, In Vitro, and In Vivo Biocompatibility Assessment
The injectable hydrated calcium phosphate bone-like paste (hCPP) was developed with suitable rheological characteristics, enabling unhindered injection through standard 23G needles. In vitro assays showed the cytocompatibility of hCPP with mesenchymal embryonic C3H10T1/2 cell cultures. The hCPP was composed of aggregated micro-sized particles with sphere-like shapes and low crystallinity. The ability of hCPP particles to adsorb serum proteins (FBS) was investigated. The hCPP demonstrated high protein adsorption capacity, indicating its potential in various biomedical applications. The results of the in vivo assay upon subcutaneous injection in Wistar rats indicated nontoxicity and biocompatibility of experimental hCPP, as well as gradual resorption of hCPP, comparable to the period of bone regeneration. The data obtained are of great interest for the development of commercial highly effective osteoplastic materials for bone tissue regeneration and augmentation.
- Open Access
- 18 May 2023
- Published by MDPI AG in Preprints.org
Injectable Hydrated Calcium Phosphate Bone-Like Paste: synthesis, In Vitro and In Vivo Biocompatibility Assessment
The injectable hydrated calcium phosphate bone-like paste (hCPP) have been developed with suitable nanoscale characteristics and unindered injection through 23G standard needles. In vitro assays showed the cytocompatibility of hCPP with mesenchymal embryonic C3H10T1/2 cell cultures. The hCPPs were identified to be composed of aggregated nano-sized particles with sphere-like shapes with low crystallinity. The ability of serum proteins (FBS) to adsorb on hCPP particles was also studied. The hCPP demonstrated high protein adsorption capacity, thereby indicating its potential in various biomedical applications. The results of the in vivo assay upon subcutaneous injection in Wistar rats indicated the nontoxicity and biocompatibility of experimental hCPP, as well as the gradual resorption of hCPP, comparable to the period of bone regeneration. The data obtained are of great interest for the development of commercial highly effective osteoplastic materials for bone tissue regeneration and augmentation.
- 18 May 2023
- Published by MDPI AG in Preprints.org
Open AccessInjectable Hydrated Calcium Phosphate Bone-Like Paste: synthesis, In Vitro and In Vivo Biocompatibility Assessment
The injectable hydrated calcium phosphate bone-like paste (hCPP) have been developed with suitable nanoscale characteristics and unindered injection through 23G standard needles. In vitro assays showed the cytocompatibility of hCPP with mesenchymal embryonic C3H10T1/2 cell cultures. The hCPPs were identified to be composed of aggregated nano-sized particles with sphere-like shapes with low crystallinity. The ability of serum proteins (FBS) to adsorb on hCPP particles was also studied. The hCPP demonstrated high protein adsorption capacity, thereby indicating its potential in various biomedical applications. The results of the in vivo assay upon subcutaneous injection in Wistar rats indicated the nontoxicity and biocompatibility of experimental hCPP, as well as the gradual resorption of hCPP, comparable to the period of bone regeneration. The data obtained are of great interest for the development of commercial highly effective osteoplastic materials for bone tissue regeneration and augmentation.